- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/40 - Benzopyrazines
Patent holdings for IPC class C07D 241/40
Total number of patents in this class: 67
10-year publication summary
|
1
|
7
|
6
|
4
|
8
|
1
|
6
|
4
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1582 |
9 |
| Intra-Cellular Therapies, Inc. | 436 |
5 |
| Astex Therapeutics Limited | 207 |
3 |
| Development Center for Biotechnology | 146 |
3 |
| Platefuse, Inc. | 8 |
3 |
| Boehringer Ingelheim International GmbH | 4493 |
2 |
| Amgen Inc. | 4427 |
2 |
| Board of Regents, The University of Texas System | 6107 |
2 |
| Georgia Tech Research Corporation | 2943 |
2 |
| BP Oil International Limited | 71 |
2 |
| Sunovion Pharmaceuticals Inc. | 244 |
2 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3304 |
2 |
| Duke Street Bio Limited | 20 |
2 |
| F. Hoffmann-La Roche AG | 7837 |
1 |
| Roche Diagnostics GmbH | 2691 |
1 |
| Roche Diagnostics Operations, Inc. | 1519 |
1 |
| FUJIFILM Corporation | 30514 |
1 |
| Semiconductor Energy Laboratory Co., Ltd. | 11821 |
1 |
| Cheil Industries Inc. | 813 |
1 |
| Ambrx, Inc. | 170 |
1 |
| Other owners | 21 |